Inquis Medical
Inquis Medical develops a proprietary single-pass thrombectomy platform designed to improve procedural efficiency and safety in the treatment of pulmonary embolism and deep vein thrombosis.
Founded in 2020, Inquis Medical is a venture-backed medical device company focused on advancing the treatment of venous thromboembolic disease. The company’s flagship AVENTUS Thrombectomy System is designed to enable physicians to safely and efficiently remove clot burden in patients with pulmonary embolism and deep vein thrombosis through a proprietary catheter design combined with autologous blood reinfusion.
Inquis Medical, Inc. operates as a privately held, clinical-stage company headquartered in Silicon Valley. The company’s foundation is built on decades of collective experience in the development, commercialization, and clinical support of novel, physician-tested medical devices intended to address unmet clinical needs and deliver lasting impact in patient care.
The Inquis Medical team is dedicated to improving the management of venous thromboembolic diseases through technological innovation. Its proprietary next-generation thrombectomy platform is designed to support efficient single-pass clot removal while minimizing blood loss, reflecting the company’s focus on procedural efficiency, safety, and improved clinical outcomes.
